Real‐world long‐term analysis of daclatasvir plus asunaprevir in patients with hepatitis C virus infection

Abstract Background and Aim This study aimed to evaluate the long‐term clinical course of patients achieving a sustained virologic response (SVR) with daclatasvir plus asunaprevir (DCV/ASV) therapy. Methods A total of 911 patients who achieved SVR with DCV/ASV were assessed. To evaluate pretreatment...

詳細記述

保存先:
書誌詳細
主要な著者: Hideki Fujii, Hiroyuki Kimura, Chitomi Hasebe, Takehiro Akahane, Takashi Satou, Atsunori Kusakabe, Yuji Kojima, Masahiko Kondo, Hiroyuki Marusawa, Haruhiko Kobashi, Keiji Tsuji, Chikara Ogawa, Yasushi Uchida, Kouji Joko, Akeri Mitsuda, Masayuki Kurosaki, Namiki Izumi
フォーマット: Artigo
言語:Inglês
出版事項: Wiley 2022-05-01
シリーズ:JGH Open
主題:
asunaprevir
daclatasvir
hepatocellular carcinoma incidence
liver function
オンライン･アクセス:https://doi.org/10.1002/jgh3.12749
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料